drugset
drugset / Trial / NCT02704559

Study to Explore Drug-drug Interactions Between DWC20155 and DWC20156 in Healthy Subjects

NCT02704559 ↗

Phase 1 Completed 40 enrolled Daewoong Pharmaceutical Co. LTD.
RandomizedCrossoverOpen-labelTreatment

Summary

A randomized, open-label, oral dose, crossover study to explore drug-drug interactions between DWC20155 and DWC20156 in healthy subjects.

Timeline

Start
2015-12
Primary completion
2016-02
Completion
2016-02

Drugs

EvaluationDrugModalityDoseRoute
Subject DWC20155 Unknown — Oral
Subject DWC20156 Unknown — Oral

Indications

No indication recorded.